Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous vs Intramuscular FSME-Immun Vaccination
NCT02511587Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2012
- Primary completion
- Jun 2015
- Modality
- Whole Inactivated Vaccines
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Medical University of Vienna. Started Oct 2012; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT02511587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511587.